274 related articles for article (PubMed ID: 2401043)
21. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents.
Naito M; Naito Y; DiGiovanni J
Carcinogenesis; 1987 Dec; 8(12):1807-15. PubMed ID: 3119244
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
23. Phenobarbital decreases hepatocyte EGF receptor expression independent of protein kinase C activation.
Meyer SA; Jirtle RL
Biochem Biophys Res Commun; 1989 Feb; 158(3):652-9. PubMed ID: 2784053
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism.
Bjorge JD; Kudlow JE
J Biol Chem; 1987 May; 262(14):6615-22. PubMed ID: 3494731
[TBL] [Abstract][Full Text] [Related]
25. Interaction of epidermal growth factor with basal and differentiating epidermal cells of mice resistant and sensitive to carcinogenesis.
Strickland JE; Jetten AM; Kawamura H; Yuspa SH
Carcinogenesis; 1984 Jun; 5(6):735-40. PubMed ID: 6327111
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of epidermal growth factor receptor threonine 654 phosphorylation by platelet-derived growth factor in protein kinase C-deficient human fibroblasts.
Davis RJ; Czech MP
J Biol Chem; 1987 May; 262(14):6832-41. PubMed ID: 3106361
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-alpha, and skin tumor promotion in wa-1 mice.
Kiguchi K; Beltrán L; Dubowski A; DiGiovanni J
J Invest Dermatol; 1997 May; 108(5):784-91. PubMed ID: 9129233
[TBL] [Abstract][Full Text] [Related]
28. Effect of retinoic acid and 12-O-tetradecanoyl phorbol-13-acetate on the binding of epidermal growth factor to its cellular receptors.
Saito M; Ueno I; Egawa K
Biochim Biophys Acta; 1982 Aug; 717(2):301-4. PubMed ID: 6288114
[TBL] [Abstract][Full Text] [Related]
29. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthrones.
DiGiovanni J; Kruszewski FH; Coombs MM; Bhatt TS; Pezeshk A
Carcinogenesis; 1988 Aug; 9(8):1437-43. PubMed ID: 3402040
[TBL] [Abstract][Full Text] [Related]
31. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
Friedman B; Frackelton AR; Ross AH; Connors JM; Fujiki H; Sugimura T; Rosner MR
Proc Natl Acad Sci U S A; 1984 May; 81(10):3034-8. PubMed ID: 6328489
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of [125I]epidermal growth factor binding to murine fibroblasts and keratinocytes by irradiation with UV-B light. Evidence for a protein kinase C-independent mechanism.
Brooks G; Goss MW; Hart IR
Carcinogenesis; 1990 Jul; 11(7):1223-7. PubMed ID: 2372880
[TBL] [Abstract][Full Text] [Related]
33. Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity.
Tartare S; Ballotti R; Lammers R; Filloux C; Chauvel A; Schlessinger J; Ullrich A; Van Obberghen E
J Cell Biol; 1992 Feb; 116(3):627-33. PubMed ID: 1309816
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS
J Biol Chem; 1990 Nov; 265(33):20517-23. PubMed ID: 2173710
[TBL] [Abstract][Full Text] [Related]
35. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.
Laskin JD; Lee E; Laskin DL; Gallo MA
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8211-5. PubMed ID: 3490664
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor 1 and insulin reduce epidermal growth factor binding to Swiss 3T3 cells by an indirect mechanism that is apparently independent of protein kinase C.
Corps AN; Brown KD
FEBS Lett; 1988 Jun; 233(2):303-6. PubMed ID: 3289969
[TBL] [Abstract][Full Text] [Related]
37. Effects of cell density and phorbol esters on the expression of epidermal growth factor receptors.
Rizzino A; Huebert C; Kuszynski C; Wilder PJ
Cytotechnology; 1991 Oct; 7(2):85-92. PubMed ID: 1367910
[TBL] [Abstract][Full Text] [Related]
38. Independent mechanisms for tumor promoters phenobarbital and 12-O-tetradecanoylphorbol-13-acetate in reduction of epidermal growth factor binding by rat hepatocytes.
Meyer SA; Gibbs TA; Jirtle RL
Cancer Res; 1989 Nov; 49(21):5907-12. PubMed ID: 2790804
[TBL] [Abstract][Full Text] [Related]
39. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
[TBL] [Abstract][Full Text] [Related]
40. Global modulation of the epidermal growth factor receptor is triggered by occupancy of only a few receptors. Evidence for a binary regulatory system in normal human fibroblasts.
Wiley HS; Walsh BJ; Lund KA
J Biol Chem; 1989 Nov; 264(32):18912-20. PubMed ID: 2808398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
